AR048002A1 - Dispersiones moleculares de drospirenona - Google Patents

Dispersiones moleculares de drospirenona

Info

Publication number
AR048002A1
AR048002A1 ARP050100923A ARP050100923A AR048002A1 AR 048002 A1 AR048002 A1 AR 048002A1 AR P050100923 A ARP050100923 A AR P050100923A AR P050100923 A ARP050100923 A AR P050100923A AR 048002 A1 AR048002 A1 AR 048002A1
Authority
AR
Argentina
Prior art keywords
compositions
drospirenona
solid
molecular dispersions
progestins
Prior art date
Application number
ARP050100923A
Other languages
English (en)
Spanish (es)
Inventor
Adrian Funke
Wagner Torsten
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of AR048002A1 publication Critical patent/AR048002A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007Drug-containing films, membranes or sheets

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ARP050100923A 2004-03-10 2005-03-10 Dispersiones moleculares de drospirenona AR048002A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04075713 2004-03-10

Publications (1)

Publication Number Publication Date
AR048002A1 true AR048002A1 (es) 2006-03-15

Family

ID=34928104

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050100923A AR048002A1 (es) 2004-03-10 2005-03-10 Dispersiones moleculares de drospirenona

Country Status (12)

Country Link
CN (1) CN1980636A (sr)
AR (1) AR048002A1 (sr)
DE (1) DE602005022952D1 (sr)
GT (1) GT200500044A (sr)
MY (1) MY143870A (sr)
PA (1) PA8625901A1 (sr)
PE (1) PE20060004A1 (sr)
RS (1) RS50975B (sr)
SV (1) SV2005002043A (sr)
TW (2) TW200609000A (sr)
UA (1) UA90263C2 (sr)
UY (1) UY28802A1 (sr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106109420B (zh) * 2016-08-11 2018-07-06 吴启旸 依普利酮固体分散体及其制剂

Also Published As

Publication number Publication date
RS50975B (sr) 2010-10-31
MY143870A (en) 2011-07-15
UA90263C2 (en) 2010-04-26
CN1980636A (zh) 2007-06-13
PE20060004A1 (es) 2006-02-16
SV2005002043A (es) 2005-11-04
PA8625901A1 (es) 2006-07-03
UY28802A1 (es) 2005-10-31
GT200500044A (es) 2005-10-31
TW200609000A (en) 2006-03-16
DE602005022952D1 (de) 2010-09-23
TW200840587A (en) 2008-10-16

Similar Documents

Publication Publication Date Title
Hodon et al. Design and synthesis of pentacyclic triterpene conjugates and their use in medicinal research
CY1109265T1 (el) Συνθεσεις που συμπεριλαμβανουν δροσπιρενονη μοριακα διασπαρμενη
BRPI0615292A8 (pt) composições e métodos para preparação de fármacos de má solubilidade em água com estabilidade aumentada
GT200500045A (es) Solidos supersaturados estabilizados de drogas lipofilicas
GT201000095A (es) Producto de dispersión sólida que contiene un compuesto a base de n-aril urea
GT200600258A (es) Derivados de n-(piridin-2-il)-sulfonamida
ECSP099030A (es) Composición farmacéutica que contiene un ácido tetrahidrofólico
CR8717A (es) Nuevos compuestos
SV2008002527A (es) Composicion farmaceutica que contiene gestagenos y/o estrogenos y 5-metil-(6s)-tetrahidrofolato ref. p-sv-80.273/ug
Fernandez-Llimos et al. The importance of using standardized terminology in titles and abstracts of pharmacy practice articles
UY29701A1 (es) Formulaciones líquidas para la administración controlada de derivados de bencisoxazol
GT201000102A (es) Producto de dispersión sólida de drogas basadas en n-aril urea
BR112014032583A2 (pt) forma farmacêutica para liberação prolongada de substâncias ativas
Carone et al. 3D‐Printed Lipid Mesophases for the Treatment of Chronic Liver Disease
AR064104A1 (es) Formas de dosificacion en microemulsion de valsartan, y metodos para elaborarlas
AR048002A1 (es) Dispersiones moleculares de drospirenona
AR055398A1 (es) Composicion farmaceutica de dispersion solida de pranlukast con mejor tasa de disolucion inicial y metodo para preparar la composicion
CL2012001085A1 (es) Un producto listo para el consumo gelatinizado a base de agua, jugo, y/o leche que comprende al menos dos masas de gel homogeneas independientes, en el que las masas de gel independientes adyacentes tienen resistencia de gel diferentes.
CL2008002163A1 (es) Derivados de 2-azetidina y 2-pirrolidina metanoaminas; sus procesos de obtencion; la composicion farmaceutica que los contienen; y sus usos.
BRPI0520568A2 (pt) uso de esqueleto de parede celular de nocardia rubra na preparação de medicamentos para infecção anti-hpv
BR112015015485A8 (pt) composição oleosa de anti-inflamatório, processo de preparação de uma composição e uso de uma composição
UY28370A1 (es) Agentes terapéuticos
Sayar et al. Chronic myeloid leukemia within a year of kidney transplant with elevated alkaline phosphatase correlated with imatinib therapy
BRPI0510906A (pt) composição farmacêutica tópica, composição para administração tópica e seu uso
CA3154077A1 (en) Microsphere-drug combination

Legal Events

Date Code Title Description
FB Suspension of granting procedure